Compositions and methods of treating muscle dystrophy
US11446387B2 · kind B2 · utility
4Cited by
95References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2021 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Mar 26, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.